• Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company...
    4 KB (208 words) - 00:20, 17 July 2025
  • Thumbnail for Encorafenib
    abdominal pain, and arthralgia. Encorafenib was developed by Novartis and Array BioPharma. In June 2018, it was approved by the FDA in combination with binimetinib...
    13 KB (1,054 words) - 07:27, 6 August 2025
  • Thumbnail for Pfizer
    treating conditions such as achondroplasia. Also in July, Pfizer acquired Array Biopharma for $10.6 billion, boosting its oncology pipeline. In August 2019,...
    192 KB (17,248 words) - 13:47, 2 August 2025
  • Thumbnail for Novartis
    from the original on 3 September 2018. Retrieved 25 January 2020. "Array BioPharma Completes Deal with Novartis for 2 Cancer Compounds". Genetic Engineering...
    153 KB (12,658 words) - 22:23, 25 July 2025
  • Thumbnail for Binimetinib
    V600E mutation in combination with encorafenib. It was developed by Array Biopharma. Binimetinib is an orally available inhibitor of mitogen-activated...
    15 KB (1,232 words) - 03:34, 15 May 2025
  • Thumbnail for Tucatinib
    cancer. It is a small molecule inhibitor of HER2. It was developed by Array BioPharma and licensed to Cascadian Therapeutics (formerly Oncothyreon, subsequently...
    21 KB (1,685 words) - 22:27, 29 May 2025
  • Thumbnail for Selumetinib
    overly active in many types of cancer. Selumetinib was discovered by Array BioPharma and was licensed to AstraZeneca.[citation needed] It has been investigated...
    26 KB (2,192 words) - 22:09, 29 May 2025
  • Thumbnail for Ipatasertib
    pathway. Ipatasertib was discovered by Genentech in collaboration with Array Biopharma and is currently in phase III trials for treatment of breast cancer...
    3 KB (143 words) - 19:23, 6 February 2025
  • Thumbnail for Larotrectinib
    tropomyosin kinase receptors TrkA, TrkB, and TrkC. It was discovered by Array BioPharma and licensed to Loxo Oncology in 2013. Larotrectinib was initially...
    11 KB (693 words) - 21:17, 29 May 2025
  • AMG – Amgen APD – Arena Pharmaceuticals ARQ – ArQule ARRY Array BioPharma ASP – Astellas Pharma AT – Arecor Therapeutics ATB – Antibe Therapeutics ATL –...
    18 KB (1,681 words) - 14:27, 30 April 2025
  • Infectious Diseases". Yahoo Finance. 9 May 2022. Retrieved 9 May 2022. "Array Biopharma Annual Report (Form 10-K)". www.sec.gov. Securities and Exchange Commission...
    3 KB (332 words) - 18:48, 3 July 2024
  • Thumbnail for Filanesib
    26664. PMC 4984525. PMID 22139909. Herper, Matthew (31 October 2013). "Array Biopharma Outlines Path To Market For New Myeloma Drug". Forbes. Retrieved 5...
    11 KB (1,110 words) - 22:35, 26 August 2023
  • Post-Intelligencer. November 6, 2001. p. D2. Retrieved January 12, 2009. "Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal...
    44 KB (4,452 words) - 21:08, 29 May 2025
  • Army's Command Post of the Future, USTRANSCOM's TransViz software, and Array BioPharma's Discovery product. CoMotion builds substantially on earlier work developed...
    3 KB (324 words) - 17:22, 2 October 2021
  • Thumbnail for BioMérieux
    automated test based on the BioFire FilmArray technology with the support of the United States Department of Defense. Lastly, bioMérieux launched development...
    13 KB (969 words) - 17:20, 17 March 2025
  • Thumbnail for Danoprevir
    lopinavir/ritonavir in a second trial. Danoprevir was initially developed by Array BioPharma then licensed to Roche for further development and commercialization...
    7 KB (487 words) - 22:34, 5 February 2025
  • as a tissue-agnostic inhibitor of TrkA, TrkB, and TrkC developed by Array BioPharma for solid tumors with NTRK fusion mutations. Due to this development...
    27 KB (3,130 words) - 04:58, 7 August 2025
  • engineered autologous cell therapy platform and Amgen's extensive array of cancer targets. Kite Pharma announced in May, that the first patient in its Phase 1/2...
    45 KB (4,188 words) - 08:48, 31 July 2025
  • Thumbnail for Kinesin-like protein KIF11
    SB-743921 from Cytokinetics/GSK, MK-0731 from Merck, filanesib (ARRY-520) (Array BioPharma), and litronesib (LY2523355) (Eli Lilly) have entered into clinical...
    57 KB (7,116 words) - 04:21, 15 July 2025
  • Thumbnail for Standard BioTools
    an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted...
    9 KB (827 words) - 18:47, 17 January 2025
  • (2007– ) Arena (1997– ) Array (Pfizer subsidiary since 2019; 1998– ) Arrowhead (2004– ) AryoGen (2009– ) Aspen Pharmacare (a pharma holding company; 1850–...
    34 KB (2,172 words) - 02:38, 4 July 2025
  • Thumbnail for Vivek Ramaswamy
    initiatives, including promoting health equity and diversity within the biopharma and biotech industries. While campaigning, Ramaswamy has downplayed his...
    126 KB (9,440 words) - 19:36, 24 July 2025
  • Thumbnail for New Enterprise Associates
    acquisitions). In 2012, its over $14 billion VC capital was invested in nearly 50 biopharma companies, through 14 funds. In 2018, former CEO of General Electric,...
    13 KB (1,089 words) - 07:23, 5 August 2025
  • Thumbnail for GenScript Biotech
    Legend Biotech, and ProBio). GenScript's stock fell on the news. Venus Feng and Yoojung Lee (May 31, 2018). "Road to Chinese Pharma Riches Runs Through the...
    21 KB (1,558 words) - 02:13, 9 June 2025
  • Thumbnail for United Therapeutics
    Therapeutics was named on Fortune's Best Workplaces in Health Care & Biopharma 2021 (third consecutive year); The Washington Post's Top Workplaces for...
    29 KB (2,621 words) - 15:14, 16 June 2025
  • Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company, PM BMS, November 20, 2019; retrieved May 20, 2020 "News Release"...
    10 KB (842 words) - 02:27, 24 June 2025
  • supplies to several countries during the COVID-19 pandemic. Fosun has a wide array of business activities, including investing in other firms, managing a number...
    33 KB (2,640 words) - 15:40, 22 May 2025
  • & Petrochemical (30%), Energy & Utilities (15%), Oil & Gas (30%), Pharma & Biopharma (10%), Metallurgy (5%) and Cement/Other (10%) industries. The ownership...
    21 KB (1,627 words) - 18:19, 10 April 2025
  • Thumbnail for Patrick Radden Keefe
    Secretary of Defense. Keefe has written investigative reports on a broad array of topics and issues. Topics include a conflict over ownership of iron reserves...
    20 KB (1,603 words) - 17:33, 6 August 2025
  • medical conditions. On January 27, 2009, the company was acquired by ARCA Biopharma, Inc. in a reverse takeover transaction. Nuvelo, Inc. was located at San...
    8 KB (988 words) - 04:16, 5 May 2025